𝕍𝕚𝕣𝕒𝕝 𝕍𝕒𝕔𝕔𝕚𝕟𝕖 𝕡𝕒𝕡𝕖𝕣 𝔹𝕒𝕥𝕔𝕙-𝕕𝕖𝕡𝕖𝕟𝕕𝕖𝕟𝕥 𝕤𝕒𝕗𝕖𝕥𝕪 𝕠𝕗 𝕥𝕙𝕖 𝔹ℕ𝕋𝟙𝟞𝟚𝕓𝟚 𝕞ℝℕ𝔸 ℂ𝕆𝕍𝕀𝔻-𝟙𝟡 𝕧𝕒𝕔𝕔𝕚𝕟𝕖

71% of the suspected adverse reactions occurred in 4.2% of the vaccine batches Numbers of suspected adverse events (SAEs), after BNT612b2 mRNA vaccination in Denmark. 27 December 2020–11 January 2022, (population 5.8 million) (According to the number of doses per vaccine batch)

Each dot represents a single vaccine batch. By 11 November 2022 (European area) 701 million doses of Pfizer given 971,021 reports of suspected adverse effects (SAEs) Clinical data on individual vaccine batch levels have not been reported (batch-dependent variation in the clinical efficacy and safety of authorized vaccines would appear to be highly unlikely)

We therefore examined rates of SAEs between different BNT162b2 vaccine batches administered in Denmark Data on all SAE cases, Danish Medical Agency (DKMA) SAE seriousness was classified as non-serious, serious..

Source-Pfizer will explain this